Lexaria Operating Income from 2010 to 2026

LEXX Stock  USD 0.70  0.02  2.78%   
Lexaria Bioscience Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income is likely to outpace its year average in 2026. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Lexaria Bioscience Corp generates from its operations. View All Fundamentals
 
Operating Income  
First Reported
2005-11-30
Previous Quarter
-2.5 M
Current Value
-1.6 M
Quarterly Volatility
871.6 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 190.8 K, Interest Expense of 107 K or Total Revenue of 426.9 K, as well as many indicators such as Price To Sales Ratio of 110, Dividend Yield of 0.0 or PTB Ratio of 57.61. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.
  
Build AI portfolio with Lexaria Stock
Check out the analysis of Lexaria Bioscience Correlation against competitors.
The evolution of Operating Income for Lexaria Bioscience Corp provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Lexaria Bioscience compares to historical norms and industry peers.

Latest Lexaria Bioscience's Operating Income Growth Pattern

Below is the plot of the Operating Income of Lexaria Bioscience Corp over the last few years. Operating Income is the amount of profit realized from Lexaria Bioscience Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Lexaria Bioscience Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Lexaria Bioscience's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.
Operating Income10 Years Trend
Slightly volatile
   Operating Income   
       Timeline  

Lexaria Operating Income Regression Statistics

Arithmetic Mean(4,491,175)
Geometric Mean2,069,383
Coefficient Of Variation(85.50)
Mean Deviation3,174,645
Median(4,141,979)
Standard Deviation3,840,095
Sample Variance14.7T
Range11.9M
R-Value(0.93)
Mean Square Error2.1T
R-Squared0.87
Slope(708,068)
Total Sum of Squares235.9T

Lexaria Operating Income History

2026-9.9 M
2025-10.5 M
2024-11.6 M
2023-5.7 M
2022-6.5 M
2021-6.5 M
2020-5.5 M

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Income-10.5 M-9.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.